MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fmed.2023.1294696

Медицинская библиотека · Frontiers in medicine · 2024

Prescription trend and lactic acidosis in patients prescribed metformin before and after the revision of package insert for allowing metformin administration to patients with moderately decreased kidney function based on real-world data from MID-NET® in Japan.

Waki Takashi, Okada Yusuke, Kinoshita Yuki, Kajiyama Kazuhiro, Ishiguro Chieko, Nakazato Yuki, Kimura Ryota, Maniwa Harumi, Horiuchi Naoya, Iguchi Toyotaka, Uyama Yoshiaki

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

This study was conducted to understand the impact of package insert (PI) revision in Japan on 18 June 2019 to allow metformin use for patients with moderately decreased kidney function (30 ≤ estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2).

METHODS

A new user cohort design was employed to examine the prescription trend and the occurrence of lactic acidosis in patients prescribed metformin before and after PI revision using the Medical Information Database Network (MID-NET®).

RESULTS

From 12 May 2016 to 31 March 2020, 5,874 patients (before, n = 4,702; after, n = 1,172) were identified as new metformin users, including 1,145 patients (before, n = 914; after, n = 231) with moderately decreased kidney function. Although no marked changes in metformin prescription were observed before and after PI revision, the daily metformin dose at the first prescription decreased after PI revision. For both before and after PI revision, less than 10 cases of lactic acidosis occurred in all patients prescribed metformin, and no lactic acidosis was observed in patients with moderately decreased kidney function.

CONCLUSION

The results of this study are useful for understanding the safety of metformin use in patients with decreased kidney function and suggest no worse impacts of PI revision in Japan, indicating no further safety concerns on metformin use in patients with moderately decreased kidney function under the situation with careful use and safety monitoring of metformin.

Для цитирования: Waki Takashi, Okada Yusuke, Kinoshita Yuki, Kajiyama Kazuhiro, Ishiguro Chieko, Nakazato Yuki, Kimura Ryota, Maniwa Harumi, Horiuchi Naoya, Iguchi Toyotaka, Uyama Yoshiaki. Prescription trend and lactic acidosis in patients prescribed metformin before and after the revision of package insert for allowing metformin administration to patients with moderately decreased kidney function based on real-world data from MID-NET® in Japan.. Frontiers in medicine. 2024. DOI: 10.3389/fmed.2023.1294696.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.